ADC Therapeutics SA Common Shares (ADCT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for ADC Therapeutics SA Common Shares, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
ADC Therapeutics SA Common Shares (ADCT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $203M. It trades at $1.62, up 1.89% today. Its overall quality score is 28 out of 100, ranked against the whole US market. 2 analysts' average target of $3.50 implies +116.0% from today's price. Kronos AI's 30-day forecast is −14.7% (3 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $3.50 |
| Low – high | $2.00 – $5.00 |
| Analysts | 2 |
| Upside to average | +116.0% |
Kronos AI 30-day forecast
| Expected close | $1.36 (−14.7%) |
| Likely range | −22.8% … +14.5% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 24 |
| Solvency | 27 |
| Growth | 32 |
| Overall | 28 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator